Skip to main content
Premium Trial:

Request an Annual Quote

Perthera, Novartis Partner on Clinical Trials for Lung, Breast Cancer

NEW YORK (GenomeWeb) – Perthera said today that it is collaborating with drugmaker Novartis to identify breast and lung cancer patients for clinical trials.

Under the collaboration, Novartis will access cancer patients who have used Perthera's Precision Cancer Analysis (PCA) service, which facilitates molecular profiling of patients' cancers. The service includes genomic, proteomic, and phosphoproteomic analyses of patient tumors.

Since launching five years ago, McLean, Virginia-based Perthera has processed around 1,000 patients using its PCA service. The company does not perform the molecular profiling itself but rather manages various aspects of the process, arranging for patient samples to be collected and then sent out to different molecular profiling firms for analysis. It then consults with oncologists and other experts to determine potential courses of therapy suggested by patients' profiles.

To date, Perthera's work has focused primarily on pancreatic cancer, but the company aims to move into profiling of other cancers.

"Our vision is to extend our global lead in offering all cancer patients the full menu and all the potential benefits of precision medicine, and our relationship with Novartis helps advance our pursuit of that goal," Andrew Mignatti, Perthera's president and CEO, said in a statement.

Financial and other terms of the agreement were not disclosed.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.